EU CEP, FDA US-DMF Certified; Tailored Solutions for Global Pharma & Health Industries

Guangzhou, China – 2026 – Guangzhou Hanfang Pharmaceutical Company Limited, a leading provider of high-end pharmaceutical lipid excipients, specialty anti-tumor APIs, and Ganoderma health products in China, today highlights its customisable egg yolk lecithin solutions for global clients. These tailored offerings address critical supply chain gaps in the pharmaceutical and health product sectors, featuring domestically developed core technologies, global compliance certifications, and flexible customization options. The company’s egg yolk lecithin products are now available for custom orders worldwide, supporting clients in over 20 countries and regions.

Core Technological Breakthroughs & Product Highlights

1. Domestic Monopoly Breakthrough: Successfully developed the first domestic injectable refined egg yolk lecithin, raising the localization rate of high-end pharmaceutical lipid excipients from 10% to 90%, breaking long-term foreign monopolies in this sector.
2. Green Integrated Technology: Pioneered a supercritical CO₂ extraction-membrane separation-chromatographic separation green production process, replacing traditional polluting methods to ensure environmental sustainability and product purity.
3. Rich Intellectual Property: Holds over 240 patents as of 2025, providing unique technological barriers to support stable and reliable customisable solutions for clients.

Global Compliance & Certifications

To meet global market access requirements, the company’s egg yolk lecithin products have obtained international certifications including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI. These certifications ensure compliance with regulatory standards in major markets across Europe, North America, and Asia-Pacific, enabling seamless integration into global pharmaceutical supply chains.

Supply Information & Customisation Services

Guangzhou Hanfang Pharmaceutical Company Limited accepts custom orders for egg yolk lecithin through its official website and global authorized distributors, with mass production and worldwide shipping available immediately. Customisable options include tailored purity levels, packaging specifications, and formulation adjustments to meet the specific needs of pharmaceutical manufacturers, health product producers, and research institutions.

Authoritative Quote

"Our customisable egg yolk lecithin solutions are designed to address the urgent need for reliable, locally sourced high-end pharmaceutical excipients in global markets," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Hanfang Pharmaceutical Company Limited. "By combining our technological breakthroughs with flexible customization services, we aim to support global clients in enhancing supply chain resilience and product quality."

Industry Background & Corporate Strategy

As a national-level specialized, sophisticated, unique, and new Little Giant enterprise recognized in 2024, Guangzhou Hanfang Pharmaceutical Company Limited plays a key role in breaking foreign technological monopolies in high-end pharmaceutical lipid excipients. The company’s customisation services align with the global trend towards personalized pharmaceutical production, helping clients meet diverse regulatory and formulation requirements while reducing reliance on imported materials.

Future Plans

Looking ahead, Guangzhou Hanfang Pharmaceutical Company Limited will continue to invest in R&D of high-end pharmaceutical lipid excipients, expanding its customisation capabilities and global distribution network. The company aims to achieve double-digit growth in revenue and profit in 2026, further strengthening its position as a trusted global supplier of customisable pharmaceutical excipients.

Company Profile

Guangzhou Hanfang Pharmaceutical Company Limited was founded in 1998, a core modern pharmaceutical enterprise under the Guangzhou Pharmaceutical Holdings Group. It operates the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, the only national-level engineering research center in the pharmaceutical lipid field. The company focuses on APIs, pharmaceutical lipid excipients, health products, and technical services, serving over 1,000 clients including B. Braun, AstraZeneca, and Kelun Pharmaceutical across more than 20 countries. Its mission is to achieve technological self-reliance, solve bottleneck problems, and ensure the safety of the pharmaceutical supply chain. More information is available at http://byshanhanfang.com/.

Contact Information

Company: Guangzhou Hanfang Pharmaceutical Company Limited
Official Website: http://byshanhanfang.com/

© 2026 Guangzhou Hanfang Pharmaceutical Company Limited. All rights reserved.